海外医薬品不足状況

ホーム > 供給不足情報 > 海外医薬品不足状況 > 2024年 > 9月

更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。

米国

カナダ

カナダの情報はありません。

オーストラリア

  • 2024.09.30
    TGAオーストラリア供給不足情報（9月22日～9月29日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgCurrentUnavailableManufacturing27/09/2024
    salbutamol sulfateInhalation, conventional3 mgCurrentUnavailableManufacturing27/09/2024
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLCurrentLimited AvailabilityManufacturing27/09/2024
    octreotideInjection, solution100 microgramCurrentLimited AvailabilityManufacturing27/09/2024
    octreotideInjection, solution500 microgramCurrentUnavailableManufacturing27/09/2024
    octreotideInjection, solution50 microgramCurrentUnavailableManufacturing27/09/2024
    buprenorphine hydrochlorideInjection, solution324 microgram/mLCurrentUnavailableManufacturing27/09/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing27/09/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing27/09/2024
    metronidazoleTablet, uncoated400 mgResolvedAvailableManufacturing27/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing27/09/2024
    tranexamic acidInjection, solution1000 mgAnticipatedAvailableCommercial Changes / Commercial viability27/09/2024
    fenofibrateTablet48 mgCurrentLimited AvailabilityManufacturing27/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnavailableManufacturing27/09/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply27/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing27/09/2024
    phenytoin sodiumCapsule, hard100 mgCurrentLimited AvailabilityManufacturing27/09/2024
    gliclazideTablet, modified release30 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply27/09/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing27/09/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing27/09/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing27/09/2024
    methylphenidate hydrochlorideTablet, modified release54 mgAnticipatedAvailableManufacturing27/09/2024
    methylphenidate hydrochlorideTablet, modified release27 mgAnticipatedAvailableManufacturing27/09/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues27/09/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing27/09/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing27/09/2024
    morphine sulfate pentahydrateCapsule, modified release120 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    morphine sulfate pentahydrateCapsule, modified release90 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    morphine sulfate pentahydrateCapsule, modified release60 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgResolvedAvailableManufacturing27/09/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing26/09/2024
    ramiprilCapsule, hard10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    propofolInjection, emulsion500 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    oxytocinInjection, solution10 IUAnticipatedAvailableManufacturing26/09/2024
    temozolomideCapsule, hard100 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues26/09/2024
    lurasidone hydrochlorideTablet, film coated40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer10.9 mg~10 mgCurrentUnavailableManufacturing26/09/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing26/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing26/09/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand26/09/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing26/09/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentLimited AvailabilityManufacturing26/09/2024
    montelukast sodiumTablet, film coated10.4 mgCurrentUnavailableManufacturing26/09/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing26/09/2024
    bisoprolol fumarateTablet, film coated2.5 mgDiscontinuedUnavailableCommercial Changes / Commercial viability26/09/2024
    bisoprolol fumarateTablet, film coated5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    bisoprolol fumarateTablet, film coated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    pamidronate disodiumInjection, concentrated3 mgCurrentUnavailableManufacturing26/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    Rabies virusInjection, powder for2.5 IUCurrentEmergency Supply OnlyManufacturing25/09/2024
    latanoprost~timolol maleateEye Drops, solution.05 mg/mL~6.83 mg/mLAnticipatedAvailableManufacturing25/09/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing25/09/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableManufacturing25/09/2024
    lurasidone hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing25/09/2024
    Rabies virusPowder3.25 IUCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    AdalimumabInjection, solution40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability25/09/2024
    propranolol hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing24/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing24/09/2024
    acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues24/09/2024
    midazolamInjection, solution5 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/09/2024
    midazolamInjection, solution1 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing24/09/2024
    buprenorphineDrug delivery system, transdermal40 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand24/09/2024
    betahistine dihydrochlorideTablet, uncoated16 mgResolvedAvailableManufacturing24/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing24/09/2024
    heparin sodiumInjection, solution10 IU/mLCurrentLimited AvailabilityManufacturing24/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing24/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal4.8 mg~.512 mgCurrentLimited AvailabilityManufacturing24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/09/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/09/2024
    olanzapine pamoate monohydrateInjection, powder for690 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues23/09/2024
    olanzapine pamoate monohydrateInjection, powder for483 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues23/09/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgResolvedAvailableManufacturing23/09/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing23/09/2024
    milrinoneInjection, concentrated10 mgCurrentLimited AvailabilityManufacturing23/09/2024
    hydromorphone hydrochlorideInjection, solution2 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    hydromorphone hydrochlorideInjection, solution10 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    hydromorphone hydrochlorideInjection, concentrated50 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    levothyroxine sodiumTablet, uncoated.05 mgAnticipatedAvailableManufacturing23/09/2024
    levothyroxine sodiumTablet, uncoated.075 mgAnticipatedAvailableManufacturing23/09/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgCurrentLimited AvailabilityUnexpected increase in consumer demand23/09/2024
    desmopressin acetateSpray, solution.1 mg/mLCurrentUnavailableProduct recall23/09/2024
    rizatriptan benzoateWafer14.53 mgCurrentLimited AvailabilityManufacturing23/09/2024
    midazolamInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing23/09/2024
    oxycodone hydrochlorideCapsule, hard5 mgAnticipatedAvailableManufacturing23/09/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply23/09/2024
    nizatidineCapsule300 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply23/09/2024
  • 2024.09.24
    TGAオーストラリア供給不足情報（9月16日～9月22日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramAnticipatedAvailableTransport / Logistic issues / Storage capacity issues22/09/2024
    gabapentinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing20/09/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing20/09/2024
    venlafaxineCapsule, modified release75 mgCurrentLimited AvailabilityManufacturing20/09/2024
    venlafaxineCapsule, modified release150 mgCurrentLimited AvailabilityManufacturing20/09/2024
    FilgrastimInjection, solution120 microgramResolvedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    FilgrastimInjection, solution480 microgramResolvedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing20/09/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand20/09/2024
    fenofibrateTablet48 mgAnticipatedAvailableManufacturing20/09/2024
    buprenorphineDrug delivery system, transdermal40 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing20/09/2024
    trimethoprimTablet, uncoated300 mgAnticipatedAvailableManufacturing20/09/2024
    lenalidomideCapsule, hard5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand20/09/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues20/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.6 mg~10 mgCurrentLimited AvailabilityManufacturing20/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.8 mg~10 mgCurrentUnavailableManufacturing20/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentLimited AvailabilityUnexpected increase in consumer demand20/09/2024
    clindamycin phosphateLotion10 mg/mLCurrentLimited AvailabilityManufacturing20/09/2024
    Epoetin lambdaInjection, solution10000 IUResolvedAvailableManufacturing19/09/2024
    omeprazoleCapsule20 mgResolvedAvailableManufacturing19/09/2024
    insulinInjection, solution100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    insulinInjection, suspension100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    insulinInjection, suspension100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin detemirInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin detemirInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing19/09/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing19/09/2024
    quetiapine fumarateTablet, film coated28.784 mgResolvedAvailableUnexpected increase in consumer demand19/09/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing19/09/2024
    cisatracurium besilateInjection, solution201 mgDiscontinuedUnavailableManufacturing19/09/2024
    Follitropin alfaInjection, solution75 IUAnticipatedAvailableManufacturing19/09/2024
    Follitropin alfaInjection, solution150 IUAnticipatedAvailableManufacturing19/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnavailableManufacturing19/09/2024
    Insulin aspartInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin aspartInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin degludec~Insulin aspartInjection, solution420 nmol/mL~180 nmol/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply19/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated82.725 mg~10 mgCurrentUnavailableManufacturing19/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing19/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing19/09/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.94 mgCurrentLimited AvailabilityUnexpected increase in consumer demand19/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentUnavailableManufacturing19/09/2024
    levothyroxine sodiumTablet, uncoated.1 mgCurrentUnavailableManufacturing19/09/2024
    levothyroxine sodiumTablet, uncoated.2 mgCurrentLimited AvailabilityManufacturing19/09/2024
    Dornase alfaSpray, solution1 mg/mLResolvedAvailableCommercial Changes / Commercial viability19/09/2024
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLAnticipatedAvailableManufacturing19/09/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing19/09/2024
    clindamycin hydrochlorideSolution10 mg/mLCurrentUnavailableManufacturing19/09/2024
    amoxicillin sodiumInjection, powder for1060 mgCurrentLimited AvailabilityManufacturing19/09/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrentUnavailableManufacturing19/09/2024
    tacrolimus monohydrateCapsule, hard1.022 mgAnticipatedAvailableManufacturing18/09/2024
    carmustineInjection, powder for100 mgResolvedAvailableManufacturing18/09/2024
    dulaglutideInjection, solution1.5 mgCurrentLimited AvailabilityManufacturing18/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgResolvedAvailableManufacturing18/09/2024
    spironolactoneTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing18/09/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing18/09/2024
    sitagliptin fumarateTablet, film coated128.497 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply18/09/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing18/09/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing18/09/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgCurrentUnavailableManufacturing18/09/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing18/09/2024
    norethisteroneTablet, uncoated350 microgramCurrentUnavailableManufacturing17/09/2024
    isosorbide dinitrateTablet, uncoated5 mgAnticipatedAvailableManufacturing17/09/2024
    codeine phosphate hemihydrate~ibuprofenTablet, film coated12.8 mg~200 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues17/09/2024
    simvastatinTablet, film coated20 mgAnticipatedAvailableManufacturing17/09/2024
    tenofovir disoproxil maleate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing17/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated10.341 mg~10 mgAnticipatedAvailableManufacturing17/09/2024
    zolpidem tartrateTablet, film coated10 mgAnticipatedAvailableManufacturing16/09/2024
    medronic acidInjection, powder for10 mgAnticipatedAvailableManufacturing16/09/2024
    gabapentinTablet, film coated600 mgResolvedAvailableManufacturing16/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/09/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated2 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    oseltamivir phosphateOral Liquid, powder for7.88 mg/mLResolvedAvailableUnexpected increase in consumer demand16/09/2024
    azithromycin dihydrateTablet, film coated524.05 mgCurrentUnavailableManufacturing16/09/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentLimited AvailabilityManufacturing16/09/2024
    irbesartanTablet, film coated300 mgAnticipatedAvailableManufacturing16/09/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing16/09/2024
    olmesartan medoxomilTablet, film coated40 mgAnticipatedAvailableManufacturing16/09/2024
    olmesartan medoxomil~hydrochlorothiazideTablet, film coated40 mg~25 mgAnticipatedAvailableManufacturing16/09/2024
    azacitidineInjection, powder for100 mgCurrentLimited AvailabilityManufacturing16/09/2024
    anastrozoleTablet, film coated1 mgAnticipatedAvailableManufacturing16/09/2024
    irbesartanTablet, film coated150 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    nebivolol hydrochlorideTablet5.45 mgAnticipatedAvailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~40 mgCurrentUnavailableManufacturing16/09/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing16/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~10.341 mgCurrentUnavailableManufacturing16/09/2024
    lenalidomideCapsule5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule15 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule25 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableManufacturing16/09/2024
    methotrexateTablet10 mgAnticipatedAvailableManufacturing16/09/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentUnavailableManufacturing16/09/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentUnavailableManufacturing16/09/2024
  • 2024.09.17
    TGAオーストラリア供給不足情報（9月9日～9月15日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    siponimod hemifumarateTablet, film coated.278 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing13/09/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing13/09/2024
    pentetic acidInjection, powder for5 mgAnticipatedAvailableManufacturing13/09/2024
    sodium pyrophosphateInjection, powder for30 mgAnticipatedAvailableManufacturing13/09/2024
    Pancreatic extractCapsule, enteric150 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/09/2024
    methotrexateInjection, solution100 mg/mLAnticipatedAvailableManufacturing13/09/2024
    acetylcysteineInjection, concentrated2 gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentLimited AvailabilityManufacturing13/09/2024
    quetiapine fumarateTablet, film coated28.784 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/09/2024
    simvastatinTablet, film coated40 mgAnticipatedAvailableManufacturing13/09/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing13/09/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing13/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgAnticipatedAvailableManufacturing13/09/2024
    mycophenolate mofetilInjection, powder for500 mgResolvedAvailableManufacturing13/09/2024
    oseltamivir phosphateCapsule, hard98.524 mgAnticipatedAvailableUnexpected increase in consumer demand13/09/2024
    flucloxacillin sodium monohydrateInjection, powder for1088.1 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues13/09/2024
    methylphenidate hydrochlorideTablet, modified release27 mgAnticipatedAvailableManufacturing13/09/2024
    phenytoin sodiumInjection, solution100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability13/09/2024
    rifabutinCapsule, hard150 mgAnticipatedAvailableManufacturing13/09/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrentUnavailableManufacturing13/09/2024
    clarithromycinTablet, film coated250 mgAnticipatedAvailableUnexpected increase in consumer demand13/09/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing12/09/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution2 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution5 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    olanzapineTablet, orally disintegrating20 mgAnticipatedAvailableManufacturing12/09/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing12/09/2024
    omeprazoleCapsule20 mgCurrentLimited AvailabilityManufacturing12/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentUnavailableManufacturing12/09/2024
    simvastatinTablet, film coated10 mgAnticipatedAvailableManufacturing12/09/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing12/09/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgCurrentLimited AvailabilityManufacturing12/09/2024
    nebivolol hydrochlorideTablet1.363 mgAnticipatedAvailableManufacturing12/09/2024
    acamprosate calciumTablet, enteric coated333 mgAnticipatedAvailableManufacturing12/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgCurrentUnavailableManufacturing12/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgCurrentUnavailableManufacturing12/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrentUnavailableManufacturing12/09/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues12/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing12/09/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableManufacturing12/09/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing12/09/2024
    amoxicillin sodiumInjection, powder for1060 mgAnticipatedAvailableManufacturing12/09/2024
    metoprolol succinateTablet, modified release47.5 mgAnticipatedAvailableManufacturing11/09/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing11/09/2024
    metoprolol succinateTablet, modified release95 mgAnticipatedAvailableManufacturing11/09/2024
    bisoprolol fumarateTablet2.5 mgCurrentUnavailableManufacturing11/09/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing11/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing11/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing11/09/2024
    citalopram hydrobromideTablet, film coated12.495 mgAnticipatedAvailableManufacturing11/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing11/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand11/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand11/09/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing11/09/2024
    tadalafilTablet, film coated10 mgAnticipatedAvailableManufacturing11/09/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentUnavailableManufacturing11/09/2024
    nizatidineCapsule, hard150 mgCurrentUnavailableManufacturing11/09/2024
    dasatinibTablet, film coated100 mgCurrentLimited AvailabilityManufacturing11/09/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgResolvedAvailableManufacturing11/09/2024
    linezolidTablet, film coated600 mgCurrentLimited AvailabilityUnexpected increase in consumer demand11/09/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing11/09/2024
    spironolactoneTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing11/09/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand11/09/2024
    nizatidineCapsule, hard300 mgCurrentUnavailableManufacturing11/09/2024
    paclitaxelInjection, concentrated6 mg/mLResolvedAvailableManufacturing11/09/2024
    baclofenTablet, uncoated25 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues11/09/2024
    escitalopram oxalateTablet, film coated25.56 mgCurrentLimited AvailabilityManufacturing10/09/2024
    dexamethasone~framycetin sulfate~gramicidinEar Drops.5 mg/mL~5 mg/mL~.05 mg/mLCurrentUnavailableManufacturing10/09/2024
    risperidoneTablet.5 mgResolvedAvailableManufacturing10/09/2024
    risperidoneTablet1 mgResolvedAvailableManufacturing10/09/2024
    gabapentinTablet, film coated800 mgCurrentUnavailableManufacturing10/09/2024
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgResolvedAvailableManufacturing10/09/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentLimited AvailabilityManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    amlodipine besilateTablet13.87 mgResolvedAvailableManufacturing10/09/2024
    ezetimibeTablet, uncoated10 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply10/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing10/09/2024
    clonidine hydrochlorideTablet100 microgramCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    cinacalcet hydrochlorideTablet, film coated33 mgResolvedAvailableManufacturing10/09/2024
    tenofovir disoproxil fumarateTablet300 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~simvastatinTablet10 mg~20 mgResolvedAvailableManufacturing10/09/2024
    mesalazineTablet, enteric coated1.6 gCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply10/09/2024
    rosuvastatin calciumTablet, film coated5.21 mgResolvedAvailableManufacturing10/09/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing10/09/2024
    indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing10/09/2024
    temozolomideCapsule, hard5 mgCurrentLimited AvailabilityManufacturing10/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentUnavailableManufacturing10/09/2024
    lanreotide acetateInjection, solution100 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing10/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentLimited AvailabilityManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing10/09/2024
    heparin sodiumInjection, solution5000 IU/mLAnticipatedAvailableManufacturing10/09/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand10/09/2024
    azithromycin dihydrateSuspension, powder for209.65 mgCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    indapamide hemihydrateTablet2.5 mgCurrentLimited AvailabilityManufacturing10/09/2024
    salbutamol sulfateInhalation1.2 mg/mLResolvedAvailableManufacturing9/09/2024
    fentanylDrug delivery system, transdermal2.063 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    fentanylDrug delivery system, transdermal8.25 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    fentanylDrug delivery system, transdermal12.375 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    galantamine hydrobromideCapsule, modified release20.512 mgResolvedAvailableManufacturing9/09/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing9/09/2024
    bosentan monohydrateTablet, film coated64.541 mgResolvedAvailableManufacturing9/09/2024
    midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing9/09/2024
    midazolamInjection, solution1 mg/mLAnticipatedAvailableManufacturing9/09/2024
  • 2024.09.09
    TGAオーストラリア供給不足情報（9月2日～9月8日）
    Active ingredientsDosage formQuantity of active ingredientsAvailabilityReasonLast updated
    mycophenolate mofetilTablet, film coated500 mgLimited AvailabilityManufacturing6/09/2024
    methotrexateInjection, solution100 mg/mLLimited AvailabilityManufacturing6/09/2024
    Follitropin alfaInjection, solution225 IUReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgUnavailableManufacturing6/09/2024
    eftrenonacog alfaInjection, powder for4000 IUUnavailableManufacturing6/09/2024
    estradiolDrug delivery system, transdermal1.17 mgUnavailableManufacturing6/09/2024
    iopromideInjection, solution498.72 mg/mLUnavailableUnexpected increase in consumer demand6/09/2024
    ezetimibeTablet10 mgUnavailableUnexpected increase in demand due to other sponsors unable to supply6/09/2024
    norethisteroneTablet, uncoated350 microgramAvailableManufacturing5/09/2024
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgAvailableManufacturing5/09/2024
    calcium folinateInjection324.1 mgAvailableManufacturing5/09/2024
    lincomycin hydrochloride monohydrateInjection, solution340.26 mg/mLReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/09/2024
    griseofulvinTablet, uncoated125 mgUnavailableManufacturing5/09/2024
    adrenaline (epinephrine)Injection, solution1 mgLimited AvailabilityManufacturing5/09/2024
    anidulafunginInjection, powder for100 mgLimited AvailabilityManufacturing5/09/2024
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLUnavailableManufacturing5/09/2024
    adrenaline (epinephrine)Injection, solution1 mgAvailableManufacturing5/09/2024
    latanoprost~timolol maleateEye Drops, solution50 microgram/mL~6.83 mg/mLAvailableUnexpected increase in consumer demand5/09/2024
    azacitidineInjection, powder for100 mgAvailableManufacturing5/09/2024
    tadalafilTablet, film coated20 mgLimited AvailabilityManufacturing5/09/2024
    flucloxacillin sodium monohydrateInjection, powder for1088.1 mgLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAvailableUnexpected increase in consumer demand5/09/2024
    tobramycinInhalation, conventional60 mg/mLUnavailableManufacturing5/09/2024
    clarithromycinTablet, film coated250 mgLimited AvailabilityManufacturing4/09/2024
    fludarabine phosphateInjection, concentrated50 mgUnavailableManufacturing4/09/2024
    clonidine hydrochlorideTablet, uncoated100 microgramLimited AvailabilityManufacturing4/09/2024
    trandolaprilCapsule, hard1 mgLimited AvailabilityManufacturing4/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgUnavailableManufacturing4/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgUnavailableManufacturing4/09/2024
    OmalizumabInjection, solution150 mgAvailableManufacturing4/09/2024
    levetiracetamInjection, concentrated500 mgAvailableManufacturing4/09/2024
    mitomycinInjection, powder for20 mgLimited AvailabilityManufacturing4/09/2024
    tenofovir disoproxil maleate~emtricitabineTablet, film coated300 mg~200 mgLimited AvailabilityManufacturing4/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgLimited AvailabilityCommercial Changes / Commercial viability4/09/2024
    celecoxibCapsule, hard100 mgLimited AvailabilityManufacturing4/09/2024
    busulfanInjection, concentrated60 mgAvailableManufacturing4/09/2024
    emtricitabine~tenofovir disoproxil succinateTablet, film coated200 mg~300.6 mgUnavailableManufacturing4/09/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgUnavailableUnexpected increase in demand due to other sponsors unable to supply4/09/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgLimited AvailabilityUnexpected increase in consumer demand4/09/2024
    clonazepamTablet, uncoated.5 mgAvailableManufacturing4/09/2024
    captoprilTablet, uncoated25 mgUnavailableManufacturing4/09/2024
    captoprilTablet, uncoated50 mgUnavailableManufacturing4/09/2024
    clindamycin phosphateLotion10 mg/mLAvailableManufacturing4/09/2024
    rizatriptan benzoateWafer14.53 mgLimited AvailabilityManufacturing4/09/2024
    leuprorelin acetateInjection, modified release45 mgAvailableManufacturing3/09/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgAvailableManufacturing3/09/2024
    magnesium chloride hexahydrate~sodium chloride~sodium lactate~glucose~calcium chloride dihydrateSolution, irrigation50.8 mg/L~5.38 g/L~4.48 g/L~15 g/L~183 mg/LLimited AvailabilityManufacturing3/09/2024
    olanzapineTablet, orally disintegrating10 mgUnavailableCommercial Changes / Commercial viability3/09/2024
    capecitabineTablet, film coated500 mgUnavailableManufacturing3/09/2024
    paracetamolInjection, solution10 mg/mLAvailableUnexpected increase in consumer demand3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.583 mg~10 mgLimited AvailabilityManufacturing3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgLimited AvailabilityManufacturing3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgAvailableManufacturing3/09/2024
    oxytocinInjection, solution10 IU/mLAvailableTransport / Logistic issues / Storage capacity issues3/09/2024
    fluorouracilInjection, solution50 mg/mLUnavailableManufacturing3/09/2024
    lacosamideTablet, film coated50 mgUnavailableManufacturing3/09/2024
    letrozoleTablet, film coated2.5 mgLimited AvailabilityManufacturing3/09/2024
    mesalazineTablet, enteric coated1.6 gAvailableTransport / Logistic issues / Storage capacity issues3/09/2024
    carmustineInjection, powder for100 mgLimited AvailabilityManufacturing3/09/2024
    betahistine dihydrochlorideTablet16 mgUnavailableUnexpected increase in consumer demand3/09/2024
    clonazepamTablet, uncoated2 mgLimited AvailabilityManufacturing3/09/2024
    azithromycin dihydrateTablet, film coated628.93 mgUnavailableManufacturing3/09/2024
    leuprorelin acetateInjection, modified release22.5 mgAvailableManufacturing3/09/2024
    propranolol hydrochlorideTablet, film coated40 mgAvailableManufacturing2/09/2024
    primidoneTablet, uncoated250 mgAvailableManufacturing2/09/2024
    povidoneiodineApplication100 mg/mLAvailableManufacturing2/09/2024
    donepezil hydrochlorideTablet, film coated10 mgUnavailableTransport / Logistic issues / Storage capacity issues2/09/2024
    donepezil hydrochlorideTablet, film coated5 mgAvailableTransport / Logistic issues / Storage capacity issues2/09/2024
    magnesium chloride hexahydrate~calcium chloride dihydrate~sodium lactate~glucose~sodium chlorideSolution, irrigation50.8 mg/L~183 mg/L~4.48 g/L~25 g/L~5.38 g/LLimited AvailabilityManufacturing2/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgUnavailableManufacturing2/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgUnavailableManufacturing2/09/2024
    solifenacin succinateTablet, film coated5 mgUnavailableManufacturing2/09/2024
    solifenacin succinateTablet, film coated10 mgUnavailableManufacturing2/09/2024
    methylphenidate hydrochlorideTablet, modified release54 mgAvailableManufacturing2/09/2024
    nizatidineCapsule, hard300 mgAvailableManufacturing2/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgUnavailableManufacturing2/09/2024
  • 2024.09.02
    TGAオーストラリア供給不足情報（8月26日～9月1日）
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    pioglitazone hydrochlorideTablet, uncoated33.06 mgAnticipatedAvailableManufacturing1/09/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLCurrentUnavailableManufacturing30/08/2024
    gentamicinInjection, solution80 mgAnticipatedAvailableManufacturing30/08/2024
    pantoprazole sodium sesquihydrateInjection, powder for45.12 mgCurrentUnavailableManufacturing30/08/2024
    griseofulvinTablet500 mgResolvedAvailableManufacturing30/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing30/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing30/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing30/08/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentLimited AvailabilityUnexpected increase in consumer demand30/08/2024
    AlteplaseInjection, powder for50 mgResolvedAvailableUnexpected increase in consumer demand30/08/2024
    montelukast sodiumTablet, film coated10.4 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/08/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentLimited AvailabilityManufacturing30/08/2024
    temozolomideCapsule, hard100 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues30/08/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing30/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues30/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing30/08/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing30/08/2024
    azithromycin dihydrateTablet, film coated524 mgAnticipatedAvailableManufacturing30/08/2024
    betahistine dihydrochlorideTablet16 mgCurrentUnavailableManufacturing30/08/2024
    bortezomibInjection, powder for2.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/08/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply30/08/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgCurrentUnavailableUnexpected increase in consumer demand30/08/2024
    timolol maleateEye Drops, solution6.83 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability30/08/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgCurrentUnavailableManufacturing30/08/2024
    tenofovir disoproxil fumarateTablet300 mgCurrentLimited AvailabilityManufacturing30/08/2024
    celecoxibCapsule, hard100 mgAnticipatedAvailableManufacturing30/08/2024
    hydromorphone hydrochlorideInjection, solution2 mgAnticipatedAvailableManufacturing30/08/2024
    lenalidomideCapsule, hard5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand30/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~13.88 mgCurrentUnavailableManufacturing30/08/2024
    tirzepatideInjection, solution5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution7.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution12.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution10 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution15 mgCurrentUnavailableCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution2.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    amidotrizoate meglumine~sodium amidotrizoateInjection, intravenous infusion260 mg/mL~40 mg/mLCurrentUnavailableManufacturing30/08/2024
    sodium chlorideInjection, solution90 mgCurrentLimited AvailabilityManufacturing30/08/2024
    sodium chlorideInjection, intravenous infusion900 mgCurrentUnavailableManufacturing30/08/2024
    timolol maleateEye Drops, solution6.84 mg/mLCurrentUnavailableManufacturing30/08/2024
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLAnticipatedAvailableManufacturing30/08/2024
    AlteplaseDiluent, not applicable10 mgResolvedAvailableUnexpected increase in consumer demand30/08/2024
    timolol maleate~dorzolamide hydrochlorideEye Drops, solution6.83 mg/mL~22.26 mg/mLCurrentUnavailableManufacturing30/08/2024
    rizatriptan benzoateWafer14.53 mgAnticipatedAvailableManufacturing30/08/2024
    prazosin hydrochlorideTablet, uncoated5.5 mgCurrentUnavailableManufacturing30/08/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentLimited AvailabilityManufacturing30/08/2024
    sevelamer hydrochlorideTablet, film coated800 mgResolvedAvailableManufacturing29/08/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/08/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand29/08/2024
    phytomenadioneInjection, solution10 mg/mLResolvedAvailableProduct recall29/08/2024
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/08/2024
    zopicloneTablet, film coated7.5 mgResolvedAvailableManufacturing29/08/2024
    escitalopram oxalateTablet, film coated25.56 mgCurrentLimited AvailabilityManufacturing28/08/2024
    amlodipine besilateTablet, uncoated6.94 mgResolvedAvailableManufacturing28/08/2024
    trihexyphenidyl (benzhexol) hydrochlorideTablet, uncoated5 mgResolvedAvailableManufacturing28/08/2024
    ondansetron hydrochloride dihydrateInjection, solution10 mgResolvedAvailableManufacturing28/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramResolvedAvailableManufacturing28/08/2024
    clonidine hydrochlorideTablet, uncoated100 microgramAnticipatedAvailableManufacturing28/08/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableManufacturing28/08/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing28/08/2024
    trandolaprilCapsule, hard.5 mgCurrentLimited AvailabilityManufacturing28/08/2024
    trandolaprilCapsule, hard1 mgAnticipatedAvailableManufacturing28/08/2024
    trandolaprilCapsule, hard2 mgCurrentLimited AvailabilityManufacturing28/08/2024
    trandolaprilCapsule, hard4 mgCurrentLimited AvailabilityManufacturing28/08/2024
    AbataceptInjection125.875 mgResolvedAvailableUnexpected increase in consumer demand28/08/2024
    timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~50 microgram/mLCurrentUnavailableUnexpected increase in consumer demand28/08/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing28/08/2024
    conjugated estrogens~bazedoxifene acetateTablet, modified release.45 mg~22.56 mgCurrentUnavailableCommercial Changes / Commercial viability28/08/2024
    cinacalcet hydrochlorideTablet33.064 mgResolvedAvailableManufacturing28/08/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentUnavailableManufacturing28/08/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing28/08/2024
    nebivolol hydrochlorideTablet1.363 mgCurrentUnavailableManufacturing28/08/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing28/08/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentLimited AvailabilityManufacturing28/08/2024
    mycophenolate mofetilTablet, film coated500 mgResolvedAvailableManufacturing28/08/2024
    mycophenolate mofetilInjection, powder for500 mgCurrentUnavailableManufacturing28/08/2024
    dasatinib propylene glycolTablet, film coated116 mgCurrentLimited AvailabilityManufacturing28/08/2024
    sitagliptin fumarateTablet, film coated128.497 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues28/08/2024
    octreotideInjection, solution100 microgram/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    vincristine sulfateInjection, solution1 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability28/08/2024
    indapamide hemihydrateTablet2.5 mgAnticipatedAvailableManufacturing28/08/2024
    zolpidem tartrateTablet, film coated10 mgResolvedAvailableManufacturing27/08/2024
    lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution21.3 mg/mL~22.7 microgram/mLResolvedAvailableManufacturing27/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing27/08/2024
    salbutamol sulfateInhalation1.2 mg/mLAnticipatedAvailableManufacturing27/08/2024
    risperidoneTablet.5 mgCurrentUnavailableManufacturing27/08/2024
    risperidoneTablet1 mgCurrentUnavailableManufacturing27/08/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentUnavailableManufacturing27/08/2024
    dopamine hydrochlorideInjection, concentrated40 mg/mLAnticipatedAvailableManufacturing27/08/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues27/08/2024
    bisoprolol fumarateTablet2.5 mgCurrentLimited AvailabilityManufacturing27/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues27/08/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableManufacturing27/08/2024
    quetiapine fumarateTablet, film coated115.12 mgAnticipatedAvailableManufacturing27/08/2024
    simvastatinTablet, film coated20 mgResolvedAvailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for110.28 mgCurrentUnavailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for551.4 mgCurrentUnavailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for1102.8 mgCurrentUnavailableManufacturing27/08/2024
    rosuvastatin calciumTablet, film coated41.68 mgResolvedAvailableCommercial Changes / Commercial viability27/08/2024
    voriconazoleInjection, powder for200 mgCurrentUnavailableManufacturing27/08/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability27/08/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply27/08/2024
    risperidoneOral Liquid, solution1 mg/mLCurrentUnavailableManufacturing27/08/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing27/08/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentUnavailableManufacturing27/08/2024
    montelukast sodiumTablet, film coated10.4 mgResolvedAvailableUnexpected increase in consumer demand27/08/2024
    mycophenolate sodiumTablet, enteric coated384.7 mgAnticipatedAvailableManufacturing27/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing27/08/2024
    carmustineInjection, powder for100 mgCurrentLimited AvailabilityManufacturing27/08/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLResolvedAvailableManufacturing27/08/2024
    sodium valproateTablet, enteric coated500 mgResolvedAvailableManufacturing27/08/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing27/08/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing27/08/2024
    flecainide acetateTablet, uncoated100 mgResolvedAvailableManufacturing27/08/2024
    enalapril maleateTablet, uncoated5 mgResolvedAvailableManufacturing27/08/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, film coated500 mgResolvedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, film coated1000 mgResolvedAvailableManufacturing27/08/2024
    baclofenTablet, uncoated25 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues27/08/2024
    famotidineTablet, film coated20 mgCurrentUnavailableManufacturing27/08/2024
    famotidineTablet, film coated40 mgCurrentUnavailableManufacturing27/08/2024
    methylphenidate hydrochlorideTablet, modified release36 mgResolvedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, modified release500 mgDiscontinuedUnavailableManufacturing26/08/2024
    perindopril erbumineTablet, uncoated2 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet, uncoated4 mgDiscontinuedUnavailableCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet, uncoated8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    Epoetin lambdaInjection, solution10000 IUCurrentLimited AvailabilityManufacturing26/08/2024
    gabapentinTablet, film coated600 mgAnticipatedAvailableManufacturing26/08/2024
    insulin~insulinInjection, suspension30 IU/mL~70 IU/mLDiscontinuedUnavailableCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet8 mgResolvedAvailableManufacturing26/08/2024
    bisoprolol fumarateTablet5 mgAnticipatedAvailableManufacturing26/08/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing26/08/2024
    bosentan monohydrateTablet, film coated64.541 mgCurrentUnavailableManufacturing26/08/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing26/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing26/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing26/08/2024
    dasatinibTablet, film coated70 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability26/08/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentUnavailableManufacturing26/08/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing26/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution5.27 mg/mL~9.1 microgram/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing26/08/2024

ドイツ

  • 2024.09.24
    BfArMボトルネック・レポート（9月17日～9月22日）
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    ポリ(スチレン-co-ジビニルベンゼン)スルホン舫-re(x:y)-((81)Rb)ルビジウム塩最初の通知20.09.2024
    ((201)Tl)塩化タリウム(I)最初の通知20.09.2024
    ナトリウム（メチルプレドニゾロン-21-コハク酸塩）注射剤または輸液用粉末ungメーカー変更変更通知20.09.2024
    乳酸シプロフロキサシンInfusionslungErhte 需要最初の通知20.09.2024
    バルプロ酸ナトリウム；バルプロイン舫レ徐放錠その他最初の通知20.09.2024
    <2>シプロフロキサシン塩酸塩（1：1） 1 H Oフィルムコート錠その他最初の通知20.09.2024
    トブラマイシン注射/輸液ung生産能力不足変更通知20.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要最初の通知20.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要変更通知20.09.2024
    アシクロビル眼軟膏生産における問題変更通知20.09.2024
    硫酸ゲンタマイシン目薬生産における問題変更通知20.09.2024
    <2>シプロフロキサシン塩酸塩（1：1） 1 H Oフィルムコート錠その他最初の通知20.09.2024
    セファクロル一水和物フィルムコート錠Erhte 需要最初の通知20.09.2024
    アジスロマイシン二水和物フィルムコート錠その他最初の通知20.09.2024
    アモキシシリン三水和物フィルムコート錠その他最初の通知20.09.2024
    パリカルシトールInjektionslungErhte 需要変更通知19.09.2024
    尿素；トレチノインクリーム生産能力不足最初の通知18.09.2024
    フシジン（Ph.Eur.）クリーム生産能力不足最初の通知18.09.2024
    エピネフリン／アドレナリンInjektionslungメーカー変更最初の通知18.09.2024
    アテノロール; クロルタリドンフィルムコート錠Erhte 需要最初の通知18.09.2024
    葉酸カルシウムInjektionslung他メーカーとの問題変更通知18.09.2024
    硫酸ビンブラスチンInjektionslung 調製用粉末生産における問題最初の通知18.09.2024
    アセメタシンハードカプセル生産における問題最初の通知18.09.2024
    イソトレチノインソフトカプセル最終リリースの問題点最初の通知17.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要変更通知17.09.2024
    塩化カルシウム二水和物；ヒスチジン；ヒスチジン塩酸塩一水和物；2-オキソペンタンジオ酸水素カリウム；塩化カリウム；塩化マグネシウム六水和物；マンニトール（Ph.Eur.）；塩化ナトリウム；トリプトファン生産における問題最初の通知17.09.2024
    ラモトリギンタブレット生産能力不足最初の通知17.09.2024
    シクロピロックス・オラミンL、皮膚に塗布する。生産能力不足変更通知17.09.2024
  • 2024.09.17
    BfArMボトルネック・レポート（9月2日～9月16日）
    有効成分投与形態理由最後のメッセージの日付
    ウロキナーゼ注射剤/輸液用粉末ungErhte 需要16.09.2024
    硫酸モルヒネ（Ph.Eur.）徐放錠バッチテストの問題点16.09.2024
    塩酸メルペロンフィルムコート錠生産能力不足16.09.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題16.09.2024
    クエン酸スフェンタニルInjektionslung生産における問題16.09.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要16.09.2024
    硫酸ゲンタマイシン眼軟膏生産における問題16.09.2024
    デキサメタゾン；硫酸ゲンタマイシン眼軟膏生産における問題16.09.2024
    塩酸プリロカインInjektionslung生産における問題14.09.2024
    タクロリムス一水和物軟膏Erhte 需要13.09.2024
    硫酸フラマイセチン(1:x) ((硫黄含有量の詳細))肌に塗布するパウダー生産能力不足13.09.2024
    エゼチミブタブレットErhte 需要13.09.2024
    エリスロマイシンエストレート経口懸濁液調製用粉末Erhte 需要13.09.2024
    シプロフロキサシン硫酸塩（1：1）Infusionslung生産における問題13.09.2024
    グルカゴン点鼻薬他メーカーとの問題12.09.2024
    塩酸メチルフェニデート徐放錠その他12.09.2024
    フォスカルネットナトリウム六水和物Infusionslungその他12.09.2024
    タクロリムス一水和物生産における問題12.09.2024
    メトホルミン塩酸塩；シタグリプチン塩酸塩一水和物フィルムコート錠その他12.09.2024
    クリンダマイシン-2-リン酸二水素塩膣乳頭Erhte 需要12.09.2024
    硫酸ビンブラスチンInjektionslung最終リリースの問題点12.09.2024
    ニトラゼパムタブレットErhte 需要12.09.2024
    オランザピンエンボン酸一水和物Erhte 需要12.09.2024
    臭化水素酸エレトリプタンフィルムコート錠その他11.09.2024
    トロクトコグ・アルファ・ペゴルInjektionslung 調製用粉末生産能力不足11.09.2024
    ナロキソン塩酸塩二水和物；オキシコドン塩酸塩（Ph.Eur.）徐放錠生産能力不足11.09.2024
    エストラジオール半水和物；酢酸ノルエチステロンフィルムコート錠その他11.09.2024
    インスリンアスパルトInjektionslung他メーカーとの問題11.09.2024
    塩酸ベタヒスチンタブレットErhte 需要11.09.2024
    <2>イバンドロン酸ナトリウム 1 H OInfusionsl調製用濃縮液ungErhte 需要11.09.2024
    セレギリン塩酸塩タブレットErhte 需要11.09.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要11.09.2024
    アジスロマイシン一水和物フィルムコート錠Erhte 需要11.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要11.09.2024
    インスリン グラルギンInjektionslung他メーカーとの問題11.09.2024
    エトポシドInfusionsl調製用濃縮液ung生産における問題11.09.2024
    アジスロマイシン二水和物フィルムコート錠Erhte 需要11.09.2024
    フェノキシメチルペニシリンカリウムフィルムコート錠生産における問題11.09.2024
    アジスロマイシン二水和物フィルムコート錠Erhte 需要11.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要11.09.2024
    臭化ロクロニウム注射/輸液ung生産における問題10.09.2024
    クラリスロマイシン経口懸濁液調製用顆粒生産能力不足10.09.2024
    パリカルシトールInjektionslungErhte 需要09.09.2024
    オクスカルバゼピン経口懸濁液その他09.09.2024
    インスリンリスプロInjektionslung 完成したペンの中生産能力不足09.09.2024
    インスリンアスパルトInjektionslungその他09.09.2024
    ペグインターフェロン アルファ-2aInjektionslungメーカー変更09.09.2024
    デュロキセチン腸溶性コーティング・ハードカプセルErhte 需要09.09.2024
    レナリドミドハードカプセルErhte 需要09.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要08.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要08.09.2024
    ヨウ化ナトリウム((123)I)06.09.2024
    鉄(III) D-グルコン酸ナトリウム水酸化物酸化物錯体 (約2:1:1:x:y)Injektionslung有効成分メーカーの問題06.09.2024
    デキサメタゾン；硫酸ゲンタマイシン眼軟膏生産における問題06.09.2024
    硫酸ゲンタマイシン眼軟膏生産における問題06.09.2024
    チモロールマレイン酸塩目薬生産における問題06.09.2024
    塩酸キナプリルフィルムコート錠その他06.09.2024
    ヒドロクロロチアジド；塩酸キナプリルフィルムコート錠その他06.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要06.09.2024
    エゼチミブタブレットErhte 需要05.09.2024
    ブプレノルフィン経皮吸収パッチErhte 需要05.09.2024
    リスペリドンデポー注射用懸濁液調製用粉末生産における問題05.09.2024
    硫酸ゲンタマイシンInjektionslung生産における問題05.09.2024
    フェンプロクーモンタブレット生産における問題05.09.2024
    エピネフリン／アドレナリンInjektionslungメーカー変更04.09.2024
    モメタゾンフロエート（Ph.Eur.）L、皮膚に塗布する。生産能力不足04.09.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要04.09.2024
    エトスクシミドLungメーカー変更04.09.2024
    酢酸メドロキシプロゲステロンタブレットその他04.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要04.09.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末Erhte 需要04.09.2024
    塩酸レボメタドンタブレットその他04.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要04.09.2024
    エトポシドInfusionsl調製用濃縮液ung生産能力不足03.09.2024
    リネゾリドInfusionslung生産における問題03.09.2024
    プレドニカルベートL、皮膚に塗布する。生産能力不足03.09.2024
    塩酸シナカルセスフィルムコート錠Erhte 需要03.09.2024
    オキシコドン塩酸塩（Ph.Eur.）徐放錠Erhte 需要03.09.2024
    エスケタミン塩酸塩Injektionslungその他02.09.2024
    エストラジオール半水和物；酢酸ノルエチステロンフィルムコート錠その他02.09.2024
    プレガバリン02.09.202402.09.2024
    オメプラゾール腸溶性コーティング・ハードカプセルErhte 需要02.09.2024
  • 2024.09.02
    BfArMボトルネック・レポート（8月23日～9月1日）
    活性物質剤形理由最終届出日
    Risedronat-Natrium-230.08.2024
    イバンドロン酸ナトリウム一水和物フィルムコーティング錠Erhte 需要30.08.2024
    エトスクシミドソフトカプセルErhte Demand2024.08.30
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要2024.08.30
    Hydromorphone hydrochlorideProlonged-release tabletErhte demand30.08.2024
    メトトレキサート二ナトリウムInjektionslungChange of manufacturer2024.08.30
    Prednisolone acetate貼付剤製造上の問題30.08.2024
    アトモキセチン塩酸塩予定info@heumann.de2024.08.29
    Metronidazol予定info@heumann.de29.08.2024
    Esketamine hydrochlorideInjektionslungOther29.08.2024
    Tacrolimus-MonohydratSalbeProbleme in der Herstellung29.08.2024
    アモキシシリン三水和物経口懸濁液用粉末Erhte demand29.08.2024
    BetahistindihydrochloridTabletteErhte Nachfrage29.08.2024
    Azithromycin-DihydratFilmtabletteErhte Nachfrage29.08.2024
    Azithromycin-MonohydratFilmtabletteErhte Nachfrage29.08.2024
    CarbamazepineProlonged-release tabletErhte request29.08.2024
    ヒドロモルフォン塩酸塩徐放錠 製造上の問題29.08.2024
    Hydromorphone hydrochlorideProlonged-release tabletManufacturing issues29.08.2024
    塩酸レミフェンタニル粉末・濃縮注射剤/輸液ungErhte demand29.08.2024
    Amitriptyline hydrochlorideProlonged release tabletOther29.08.2024
    シナカルセット塩酸塩フィルムコーティング錠Erhte request28.08.2024
    VandetanibManufacturing issues2024.08.28
    ヒドロモルフォン塩酸塩徐放錠製造上の問題28.08.2024
    セファドロキシル一水和物経口懸濁液用粉末剤Erhte 需要28.08.2024
    オクスカルバゼピン経口懸濁液その他2024.08.28
    レミフェンタニル塩酸塩注射用濃縮製剤または輸液用粉末ungProblems with the other manufacturer27.08.2024
    Remifentanil hydrochloridePowder f・a concentrate for preparation of injection/InfusionlungErhte demand27.08.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte Demand27.08.2024
    オフロキサシン点眼薬Manufacturing における問題2024.08.27
    Valganciclovir hydrochloridePowder for oral preparation LungProblems in manufacture26.08.2024
    メサラジン徐放錠Erhte request26.08.2024
    Morphinsulfat (Ph.Eur.)徐放性錠剤生産能力不足26.08.2024
    BuprenorphinhydrochloridSublingualtabletteProbleme in der Herstellung26.08.2024
    Salbutamolsulfatなしservice.info@gsk.com25.08.2024
    Cyclopentolate hydrochlorideEye dropsManufacturing issues23.08.2024
    Remifentanil hydrochloridePowder f・a concentrate for preparation of injection/InfusionlungErhte demand23.08.2024

フランス

  • 2024.09.30
    ANSMフランス供給不足情報（9月23日～9月29日）
    ステータス (英語)アップデートスペシャルティ
    回復2024年9月27日レミフェンタニルビアトリス1mg、注射・輸液用粉末 – [レミフェンタニル（塩酸塩］
    在庫切れ2024年9月27日ラシリクス リタード 60mg、カプセル – [フロセミド］
    供給の緊張2024年9月27日シムレクト 20mg、注射用または輸液用粉末および溶剤 – [バシリキシマブ（哺乳類/マウス/Sp2/O）
    供給の緊張2024年9月27日マキシドロール眼軟膏 – [デキサメタゾン、ネオマイシン（硫酸塩）、ポリミキシンB（硫酸塩）
    供給の緊張2024年9月27日トラボプロスト／チモロール40μg／mL＋5mg／mL、点眼液-［チモロール（マレイン酸塩）、トラボプロスト］。
    供給の緊張2024年9月27日ヒドロコルチゾン・アップジョン 500mg、注射剤 – (ヒドロコルチゾン（コハク酸水素ナトリウム）)
    回復2024年9月27日ジペンタム錠500mg「オルサラジンナトリウム
    回復2024年9月27日アビラテロンアロー500mg、フィルムコーティング錠 – [abiraterone］
    回復2024年9月27日ノジナン25mg/ml、アンプル注射液（I.M.）-［レボメプロマジン（塩酸塩］
    供給の緊張2024年9月27日リネゾリド 600mg、フィルムコーティング錠 – [linezolid］
    供給の緊張2024年9月27日ロバマイシン150万国際単位、非経口用凍結乾燥品 – [スピラマイシン（アジピン酸塩）
    在庫切れ2024年9月26日ゾフレン2mg/ml、アンプル注射液（静注）、（1箱1アンプル4ml）-［オンダンセトロン］。
    供給の緊張2024年9月26日クエチアピンLP（ゼロケルLP）50mg、300mg、400mg徐放錠 – [クエチアピン（フマル酸塩）
    供給の緊張2024年9月25日ロピニロール0.25mg、0.5mg 1mg、2mg、5mgフィルムコート錠 – [ropinirole］
    在庫切れ2024年9月25日ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒40ml入りボトル – [セフロキシム・アキセチル］
    回復2024年9月24日ラモトリギン 5mg、25mg、50mg 100mg、200mg、散剤またはチュアブル錠 – [lamotrigine］
    供給の緊張2024年9月24日クラリスロマイシン、250mgおよび500mg、徐放性フィルムコーティング錠、フィルムコーティング錠 – ［クラリスロマイシン］
    回復2024年9月23日オンダンセトロン アコード 2mg/ml、注射用液 – [オンダンセトロン］
    供給の緊張2024年9月23日Tcaps62.5マイクログラム、ソフトカプセル – [レボチロキシン］
  • 2024.09.24
    ANSMフランス供給不足情報（9月16日～9月22日）
    ステータス (英語)アップデートスペシャルティ
    回復2024年9月23日オンダンセトロン アコード 2mg/ml、注射用液 – [オンダンセトロン］
    供給の緊張2024年9月23日Tcaps 62.5マイクログラム、ソフトカプセル – [レボチロキシン］
    供給の緊張2024年9月20日メチルフェニデート・アローLP、徐放カプセル – [塩酸メチルフェニデート]。
    回復2024年9月20日ジプロステン、プレフィルドシリンジ注射用懸濁液 – [ベタメタゾン（ジプロピオン酸エステル）、ベタメタゾン（リン酸エステルナトリウム］
    回復2024年9月19日スガマデクス100mg/mL、注射用液2mLおよび5mLバイアル – ［スガマデクスナトリウム］
    供給の緊張2024年9月19日ビタミンB12デラグランジュ 1000μg/2mL、注射剤（IM）およびドリンク剤 – [シアノコバラミン］
    供給の緊張2024年9月19日ビタミンB12ゲルダ1000μg/4mL、注射剤（IM）およびドリンク剤 – [シアノコバラミン］
    回復2024年9月18日コンフェロポート0.5mg徐放カプセル – [タクロリムス］
    回復2024年9月18日キシロカイン10mg/ml アドレナリン0.005mg/ml、注射用溶液 – [リドカイン-アドレナリン］
    販売終了2024年9月18日アンコチル1％輸液 – [フルシトシン］
    回復2024年9月17日リアメット20mg/120mg、錠剤 – [アルテメテル、ルメファントリン］
    回復2024年9月17日エスペラル500mg、錠剤 – [ジスルフィラム］
    供給の緊張2024年9月16日アミカシンビアトリス250mg、500mg、1g、バイアル入り注射液用粉末 – [アミカシン（硫酸塩）
    回復2024年9月16日フレカイニドLP 50mg、100mg、150mg、200mg徐放カプセル – [フレカイニド（酢酸塩］
    回復2024年9月16日クチナール200mg/4mL、注射用液の粉末および溶剤 – [フェノバルビタールナトリウム］
    供給の緊張2024年9月16日ターシャン50mg/5ml、アンプル入り注射液 – [シアメマジン］
    供給の緊張2024年9月16日ビクトーザ 6mg/ml、プレフィルドペン注射液 – [リラグルチド］
  • 2024.09.17
    ANSMフランス供給不足情報（9月9日～9月15日）
    ステータス (英語)アップデートスペシャリティ (英語)
    供給の緊張16 2024年9月アミカシンビアトリス250mg、500mg、1g、バイアル入り注射液用粉末 – [アミカシン（硫酸塩）
    販売中止16 9月 2024フレカイニドLP 50mg、100mg、150mg、200mg徐放カプセル – [フレカイニド（酢酸塩］
    販売中止2024年9月16日クチナール200mg/4mL、注射用液の粉末および溶剤 – 【フェノバルビタールナトリウム
    供給の緊張16 9月 2024エスペラル500mg、錠剤 – [ジスルフィラム］
    供給の緊張16 9月 2024ターシャン50mg/5ml、アンプル入り注射液 – [シアメマジン］
    供給の緊張16 9月 2024ビクトーザ 6mg/ml、プレフィルドペン注射液 – [リラグルチド］
    供給の緊張13 2024年9月モキシフロキサシン 400 mg フィルムコート錠 – [moxifloxacin］
    供給の緊張2024 年 9 月 12 日コンサータLP、徐放錠 – [塩酸メチルフェニデート]。
    販売中止2024年9月12日ホメピゾールAP-HP 5mg/mL、輸液用希釈液 – [ホメピゾール（硫酸塩デ］
    供給の緊張2024 年 9 月 12 日オゼンピック0.25mg、0.5mg、1mg、プレフィルドペン注射液 – [セマグルチド（酵母/サッカロマイセス・セレビシエ）]。
    販売中止2024年9月11日三酸化ヒ素マイラン 1 mg /ml、輸液用希釈液 – [三酸化ヒ素］
    在庫切れ2024年9月11日ゾフレン2 mg/ml、注射用アンプル（静注）2 mlおよび4 mlアンプル入り溶液 – [オンダンセトロン］
    供給の緊張10 9月 2024ビルトリシド 600mg、フィルムコーティング錠、四分包 – [Praziquantel］
    販売中止2024年9月9日リドカイン 20mg/ml アドレナリン 0.005mg/ml アゲタント、注射液 – [リドカイン-アドレナリン］
    販売中止2024 年 9 月 9 日リドカイン 10mg/ml アドレナリン 0.005mg/ml アグエタント、注射用液 – [リドカイン-アドレナリン］
    販売中止2024年9月9日パゼニール5mg/mL、輸液用散剤 – [パクリタキセル］
  • 2024.09.10
    ANSMフランス供給不足情報（9月2日～9月8日）
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年9月6日Tercian 40 mg/ml, solution buvable en gouttes – [cyamémazine]
    在庫切れ2024年9月6日Étoposide Accord 20 mg/ml, solution à diluer pour perfusion – [étoposide]
    在庫切れ2024年9月6日Méthotrexate Accord 100 mg/mL, solution à diluer pour perfusion – [méthotrexate]
    供給の緊張2024年9月5日Calcidia 1,54 g, granulé pour suspension buvable en sachet-dose – [calcium (carbonate de)]
    在庫切れ2024年9月5日Lasilix Retard 60 mg, gélule – [furosémide]
    在庫状況2024年9月5日Étoposide Teva 20 mg/ml, solution à diluer pour perfusion – [étoposide]
    供給の緊張2024年9月4日Praluent 300 mg, solution injectable en stylo pré-rempli – [alirocumab (mammifere/hamster/cellules cho)]
    在庫切れ2024年9月4日Pamidronate de sodium Hospira 9 mg/ml, solution à diluer pour perfusion – [sodium (pamidronate de)]
    供給の緊張2024年9月4日Rythmodan 250 mg à libération prolongée, comprimé enrobé – [disopyramide (phosphate de)]
    在庫切れ2024年9月4日Ultiva 1 mg, poudre pour solution injectable ou pour perfusion – [rémifentanil (chlorhydrate de)]
    供給の緊張2024年9月4日Palipéridone Teva, suspension injectable à libération prolongée – [palipéridone]
    在庫切れ2024年9月4日Rémifentanil Viatris 1 mg, poudre pour solution injectable ou pour perfusion – [rémifentanil (chlorhydrate de)]
    販売中止2024年9月3日Androtardyl 250 mg/1 ml, solution injectable intramusculaire – [testostérone (énantate de)]
    供給の緊張2024年9月2日Héparine calcique 25 000 UI/mL, solution injectable en seringue pré-remplie (S.C.) de 0,2 mL et 0,3 ml, Calciparine 5 000 UI/0,2 ml et 7 500 UI/0,3 ml, solution injectable en seringue pré-remplie (S.C.) – [héparine calcique]
    発売日2024年9月2日Thérasolv 100 000 U et 500 000 UI, poudre pour solution injectable/pour perfusion – [urokinase]
    引き渡し2024年9月2日Tranxène 20 mg/2 ml, lyophilisat et solution pour usage parentéral – [clorazépate dipotassique]
  • 2024.09.02
    ANSMフランス供給不足情報（8月19日～9月1日）
    ステータス (英語)アップデートスペシャリティ (英語)
    供給の緊張2024年8月30日コアガデックス500 IU、注射用溶液の粉末および溶媒 – [ヒト凝固第X因子]。
    供給の緊張2024年8月30日ファストルテック 1.5mg/ml、粉末、輸液希釈用溶剤 1mlガラスアンプル – 【ラスブリカーゼ
    在庫切れ2024年8月30日アトラキュリウム ホスピーラ 10mg/ml、注射用溶液（50mg/5mlアンプル×5箱） – [atracurium］
    在庫切れ2024年8月27日リアメット 20mg/120mg、錠剤 – [アルテメテル、ルメファントリン］
    供給の緊張2024年8月27日ペガシス90マイクログラム、135マイクログラムおよび180マイクログラム注射液（プレフィルドシリンジ）-［ペグインターフェロン アルファ-2a
    再出荷2024年8月27日オンダンセトロン ビアトリス 2mg/ml、注射用液（I.V.） – [オンダンセトロン］
    供給の緊張2024年8月26日リタリンLP 20mg、30mg、40mg、徐放性カプセル – [塩酸メチルフェニデート
    供給の緊張2024 年 8 月 22 日メチルプレドニゾロン ビアトリス 40mg、注射液用粉末（IM-IV）-（メチルプレドニゾロン（コハク酸水素塩）
    供給の緊張2024 年 8 月 21 日コンサータLP、徐放錠 – （塩酸メチルフェニデート）
    供給の緊張2024 年 8 月 21 日チベラル500mg、輸液 – [オルニダゾール］
    再出荷2024年8月20日フルオロウラシル テバ 50mg/ml、輸液用希釈液、100ml瓶 – ［フルオロウラシル］
    再出荷2024年8月20日Celestene Chronodose 5.70mg/ml、注射用懸濁液 – Celestene 4mg/1ml、注射用溶液 – [ベタメタゾン（リン酸エステルナトリウム］
    供給の緊張2024年8月20日プラルエント300mg、プレフィルドペン注射液 – [アリロクマブ（哺乳類／ハムスター／cho細胞）
    供給の緊張2024年8月20日プラルエント150mg、プレフィルドペン注射液 – [アリロクマブ（哺乳類／ハムスター／cho細胞）
    供給の緊張2024年8月20日トリフルカン 40mg/ml、経口懸濁用粉末 – [フルコナゾール］
    在庫切れ2024年8月19日マイコスタチン 100 000 IU/ml、経口懸濁液 – [ナイスタチン］

英国

EU

  • 2024.09.04
    EMA：Update on Ozempic (semaglutide) and Victoza (liraglutide): Supply shortage

    9月2日公開のEMAによる公開書簡：当初2024年9月には改善予定であったが、特に低用量での供給不足が継続。

    https://www.ema.europa.eu/en/documents/dhpc/direct-healthcare-professional-communication-dhpc-update-ozempic-semaglutide-victoza-liraglutide-supply-shortage_en.pdf

     

    所管の要約（Summary）の日本語訳

    • 注射用グルカゴン様ペプチド-1受容体作動薬(GLP-1 RA)であるオゼンピックOzempicに対する需要の高まりと、一部の製造拠点における生産能力の制約により、品切れや在庫切れを含む供給不足が生じている。
    • Ozempicの低用量製剤である0.25mgおよび0.5mgの供給状況は悪化しており、2024年第4四半期まで全用量で断続的な品薄状態が予想される。
    • そのため、供給状況が改善するまで、Ozempicによる新規患者の治療開始を制限することを継続することが推奨される。これは2024年9月までに改善する見込みである。
    • ノボ ノルディスクは、Ozempic(週1回)の供給量を増やすため、2023年第4四半期に一時的にヴィクトーザVictoza(1日1回)の供給量を減らした。これにより、生産能力の最適化が図られる。これにより、より多くの患者の治療が可能になることが期待される。2024年第1四半期以降、EU/EEA諸国ではVictozaの供給状況が改善しているが、一部の国では依然として断続的な品薄状態が続いている。すでに治療を受けている患者が治療を継続できるよう、新規患者にはVictozaの投与を開始すべきではない。
    • 供給不足は品質上の欠陥や安全性の問題とは関係ない。
    • 現在治療中の患者にOzempicまたはVictozaが入手できない場合は、臨床判断と現地のガイドラインに基づき、患者を別のGLP-1受容体作動型注射薬または他の適切な代替薬に安全に切り替えるべきである。

     

  • 2024.09.04
    EMA shortages catalogue　2024年8月更新分

    Amoxicillin and amoxicillin/clavulanic acid supply shortage
    Reference Number:EMA/27040/2023 Rev.1
    First published: Last updated: View

    Fluorouracil (solution for injection or infusion, various strengths) supply shortage
    Reference Number:EMA/333979/2024
    First published: View

    Cisplatin (solution for injection, various strengths) supply shortages
    First published: View

このページの先頭へ戻る